In early September 2026, Omda completed the rollout of Omda Cytodose across the South-Eastern Norway Regional Health Authority. Norway’s largest health region serves more than half of the country’s population. This milestone further strengthens Omda Cytodose’s position as the market-leading oncology medication management software in Norway and Sweden.
Omda Cytodose is also expanding in Finland, where its first customer went live in March 2025.
Over the past two decades, Omda Cytodose has achieved strong organic growth while improving its financial sustainability. Its substantial installed customer base, combined with recent rollouts in Norway and Sweden and its emerging presence in Finland, provides a solid foundation for continued growth.
Read the full article about the regional rollout of Omda Cytodose at omda.com/news